Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 10
|
| Page
10 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
Study finds gene linked to aggressive prostate cancer
Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer. view more (2007-12-12)
AUA counters mainstream recommendations with new best practice statement on PSA testing
he American Urological Association (AUA) today issued new clinical guidance - which directly contrasts recent recommendations issued by other major groups - about prostate cancer screening, asserting that the prostate-specific antigen (PSA) test should be offered to well-informed, men aged 40 years or older who have a life expectancy of at least... view more... (2009-04-28)
New treatment option studied for bladder cancer
A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia. view more (2007-10-30)
Researchers testing virus-gene therapy combination against melanoma
Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease. view more (2009-07-02)
Obese women disadvantaged in both breast cancer treatment and diagnosis
Obese women with breast cancer have worse disease outcomes and also tend to present to their doctor for the first time with more advanced disease. view more (2008-04-16)
Cancer patients in India cheated of appropriate care
A letter in this week's BMJ charges the medical community in India with a "commercialisation of suffering and prolongation of lucrative illness." Dr Chatuverdi, Assistant Surgeon at Tata Memorial Hospital in Mumbai states that, in a country with 3 million cancer sufferers - of whom 80 per cent are incurable - there are only 20 dedicated... view more... (2003-05-21)
Study shows combination of immune substances to be safe
New research has shown that the immune-stimulating hormone known as interleukin-12 (IL-12) can safely be administered with interferon, another immune-system protein, as an experimental therapy for some cancers. view more (2005-12-12)
Focus on treating malnutrition in cancer patients, researchers say
Cancer patients who are malnourished experience significantly greater levels of psychological distress than those who are more adequately nourished, according to new results reported at the European Society for Medical Oncology's Symposium on Cancer and Nutrition (Zurich, 20-21 March 2009). view more (2009-03-23)
News from Cancer: Disparities in head and neck cancer patients
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer. view more (2008-10-06)
Vitamin A analog is a potential lung cancer preventative with few side effects
Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer. view more (2006-01-18)
New type of drug shows promise in attacking melanoma in an innovative way
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. view more (2007-09-27)
Preventing lung scarring may extend lives of lung cancer patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life. view more (2007-10-30)
Height linked to risk of prostate cancer development and progression
A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies. view more (2008-09-03)
Study shows more than half of esophageal cancer patients now survive
In part because the nature of the disease has changed, nearly 50 percent of patients with esophageal cancer that undergo an advanced surgical procedure now survive for five years, not 20 percent as once thought view more (2006-04-12)
Mayo Clinic finds aggressive surgery best option for advanced-stage ovarian cancer patients
Mayo Clinic Cancer Center researchers report aggressive surgical removal of as much cancer as possible throughout the abdomen in ovarian cancer patients is the best option for most women. view more (2006-01-10)
Gene chip data improved therapy in some patients with incurable cancer
Like many oncologists, Eric P. Lester, M.D., was faced with a dilemma: seven patients with advanced, incurable cancer, an arsenal of drugs that may or may not help them, and not enough solid proof about treatment efficacy to guide him. view more (2007-09-20)
Taxol with avastin produces noteworthy results
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine. view more (2007-12-28)
RNA splicing factor implicated in ovarian tumor cell growth
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago. view more (2007-04-10)
Blow for hair link to breast cancer
The promising link between certain properties in human hair which could have potentially helped in diagnosis of breast cancer is "dubious" according to research published today in the Institute of Physics journal, Physics in Medicine and Biology. Dr Mark Sutton of the McGill University in Canada and colleagues have found no clear association... view more... (2002-04-26)
Brain irradiation in lung cancer
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after... view more... (2009-06-04)
|
|
| Page
10 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
